Harendra Kumar of Elara Capital is of the view that one may hold Sun Pharmaceutical Industries for long term.
Harendra Kumar of Elara Capital told CNBC-TV18, " Sun Pharmaceutical is a long-term hold even at this point in time, in fact people had little clarity on their new filings and the growth from hereon and by acquisition of Ranbaxy Laboratories they have shown their commitment towards growth. Therefore, this is a fantastic pick and from hereon Sun Pharma structurally will continue to do well. There are no doubts about whether to hold Sun Pharma or not at this given point of time."
At 11:21 hrs Sun Pharmaceutical Industries was quoting at Rs 623.20, up Rs 35.95, or 6.12 percent.
The share touched its 52-week high Rs 653.10 and 52-week low Rs 437.25 on 03 March, 2014 and 10 April, 2013, respectively.
Anda sedang membaca artikel tentang
Hold Sun Pharmaceutical Industries: Harendra Kumar
Dengan url
https://rokokkanker.blogspot.com/2014/04/hold-sun-pharmaceutical-industries.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Hold Sun Pharmaceutical Industries: Harendra Kumar
namun jangan lupa untuk meletakkan link
Hold Sun Pharmaceutical Industries: Harendra Kumar
sebagai sumbernya
0 komentar:
Posting Komentar